The weight-loss drug Ozempic could increase the risk of vision loss, a new study found. Ozempic has been hailed as a gamechanger with the potential to save millions of lives, and billions of pounds. Illnesses caused by obesity cost the NHS more than £11 billion per year,

A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and their newer cousin, Mounjaro – are expensive, and mostly only available on private prescription.

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional — and often ineffective — advice to “eat less and exercise more.

Novo Nordisk A/S’s blockbuster shot Ozempic was linked to an increased risk of a rare form of vision loss in a study that backs up Harvard University research published earlier this year.

Novo Nordisk A/S’s blockbuster shot Ozempic was linked to an increased risk of a rare form of vision loss in a study that backs up Harvard University research published earlier this year. Most Read from BloombergHong Kong's Expat Party Hub Reshaped by Chinese InfluxBrace for a Nationwide Shuffle of Corporate HeadquartersHow California Sees the World,

The drug is usually prescribed to those with diabetes